New malaria vaccine shows great promise in early clinical trials

Malaria is the leading deadly disease on the continent, killing more than 400,000 people a year. A potential malaria vaccine has proven to be about 77 per cent effective in early clinical trials, suggesting it could be a possible breakthrough in the fight against the disease. Professor Halidou Tinto, Principal Investigator of the vaccine trial spoke with CNBC Africa for more.

Mon, 26 Apr 2021 14:52:23 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.